NCT02491632View on ClinicalTrials.gov

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 13, 2015

Primary Completion Date

March 28, 2019

Study Completion Date

December 31, 2026

Conditions
Advanced Malignant NeoplasmFatigueMetastatic Malignant NeoplasmRecurrent Malignant NeoplasmRefractory Malignant Neoplasm
Interventions
DRUG

Dexamethasone

Given PO

BEHAVIORAL

Exercise Intervention

Complete a graded resistance exercise program and a walking regimen

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT02491632 - Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter